BAI3, CDX2 and VIL1: a panel of three antibodies to distinguish small cell from large cell neuroendocrine lung carcinomas

Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study

(2013) J. Le Treut et al.   ANNALS OF ONCOLOGY

A novel evolutionarily conserved domain of cell-adhesion GPCRs mediates autoproteolysis

(2012) Demet Araç et al.   EMBO JOURNAL

Interobserver Variability in Diagnosing High-Grade Neuroendocrine Carcinoma of the Lung and Comparing It with the Morphometric Analysis

(2012) Seung Yeon Ha et al.   Korean Journal of Pathology

Novel strategies for the treatment of small-cell lung carcinoma

(2011) William N. William et al.   Nature Reviews Clinical Oncology

Small cell carcinoma of the lung and large cell neuroendocrine carcinoma interobserver variability

(2010) Michael A den Bakker et al.   HISTOPATHOLOGY

Diverse somatic mutation patterns and pathway alterations in human cancers

(2010) Zhengyan Kan et al.   NATURE

Lung tumours with neuroendocrine differentiation

(2009) William D. Travis   EUROPEAN JOURNAL OF CANCER

Cdx2 and the Brm-type SWI/SNF complex cooperatively regulate villin expression in gastrointestinal cells

(2009) Nobutake Yamamichi et al.   EXPERIMENTAL CELL RESEARCH

COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer

(2009) Simon A. Forbes et al.   NUCLEIC ACIDS RESEARCH

High-grade neuroendocrine carcinoma of the lung: Comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma

(2009) Lihua Sun et al.   PATHOLOGY INTERNATIONAL

Detection of tumor-specific autoantibodies in sera of patients with lung cancer

(2008) Ryo Nagashio et al.   LUNG CANCER

Stabilization of RNA during laser capture microdissection by performing experiments under argon atmosphere or using ethanol as a solvent in staining solutions

(2008) M. Clement-Ziza et al.   RNA